lobbying_activities
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
234 rows where filing_period = "second_quarter", filing_year = 2009 and issue_code = "PHA" sorted by filing_year descending
This data as json, CSV (advanced)
Suggested facets: filing_type, income_amount, received_date (date)
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year ▲ | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 743682 | RUBICON ADVISORS, LLC e3fa9c29-7b9e-419f-a67a-d5beb5a109b0 | 2A | RUBICON ADVISORS, LLC | 315091 | GILEAD SCIENCES | 2009 | second_quarter | PHA | H.R. 822, H.R. 1943, H.R. 6114, S-2969 | 75000 | 0 | 0 | 2009-02-10T20:11:51-05:00 | ||
| 781046 | HAMILTON ADVISORS INC. 27d94c41-7ce6-4a38-8f6f-ecc2d591c7bd | 2T | HAMILTON ADVISORS INC. | 400306434 | SANOFI-AVENTIS | 2009 | second_quarter | PHA | TRICARE | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 1 | 2009-06-22T11:03:01-04:00 | |
| 781225 | HOLLAND & KNIGHT LLP 3e1d1ba7-0248-442c-8652-01ac059f3e92 | Q2 | HOLLAND & KNIGHT LLP | 18466 | NATIONAL HEMOPHILIA FOUNDATION | 2009 | second_quarter | PHA | Blood and blood product safety; issues related to blood product approvals. | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 40000 | 0 | 0 | 2009-06-25T11:18:07-04:00 | |
| 781234 | HOLLAND & KNIGHT LLP 79423472-9491-465b-86be-f526788b95d5 | Q2 | HOLLAND & KNIGHT LLP | 18466 | AMERICAN SOCIETY OF HEMATOLOGY | 2009 | second_quarter | PHA | Hematology and Oncology drug research and approval issues. | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 20000 | 0 | 0 | 2009-06-25T11:21:11-04:00 | |
| 781487 | PROCESS HANDLER ET AL. FOR HIRE, INC. 6b430242-bc3a-45b9-9270-300e52094e09 | 2T | PROCESS HANDLER ET AL. FOR HIRE, INC. | 81830 | MR BEVERLY DWAYNE WALKER | 2009 | second_quarter | PHA | Several postage-paid postcards addressed to several various U.S. federal executive officials and agencies, several financial houses and the Bristol-Myers Squibb Company and dated June 10, 2009, regarding various unfinished, outstanding matters and concerns. Several postage-paid postcards addressed to all the Members, inclusive, officers, inclusive, operatives, inclusive, et al., inclusive, of the National Security Council of the United States of America et al., inclusive, all the Members, inclusive, officers, inclusive, operatives, inclusive, et al., inclusive, of the United Nations et al., inclusive, via whomever is the current President of the United Nations Security Council et al., inclusive, Deutsche Bank AG, UBS AG and the Bristol-Myers Squibb Company and dated June 10, 2009, regarding various unfinished, outstanding matters and concerns. | Central Intelligence Agency (CIA),Defense, Dept of (DOD),Defense Intelligence Agency (DIA),Director of National Intelligence (ODNI),Executive Office of the President (EOP),Federal Bureau of Investigation (FBI),Housing & Urban Development, Dept of (HUD),Joint Chiefs of Staff,Natl Economic Council (NEC),Natl Security Agency (NSA),Natl Security Council (NSC),Office of Policy Development,President of the U.S.,Securities & Exchange Commission (SEC),State, Dept of (DOS),Vice President of the U.S.,White House Office | 0 | 1 | 2009-06-29T18:34:17-04:00 | ||
| 781607 | CYBER SECURITY RESEARCH CONSULTANTS, LLC b7f97e21-0ff2-464e-b9d9-084964932659 | Q2 | CYBER SECURITY RESEARCH CONSULTANTS, LLC | 91694 | PDFRAZER CONSULTING INC CANADIAN INTERNATIONAL PHARMACY ASSOCIATION | 2009 | second_quarter | PHA | Food and Drug Safety Globalization Act Monitoring Dorgan-Snowe drug reimportation from Canada Health Care Reform | HOUSE OF REPRESENTATIVES,SENATE | 15000 | 0 | 0 | 2009-06-30T15:31:45-04:00 | |
| 782378 | MEREDITH MCGEHEE 3020a205-6efc-4501-bff6-31d814b156cc | Q2 | MEREDITH MCGEHEE | 79858 | INTERNATIONAL AIDS VACCINE INITIATIVE | 2009 | second_quarter | PHA | funding for programs to develop AIDS vaccine targeted toward the developing world; research and development programs aimed at the AIDS epidemic; tax issues affecting AIDS vaccine programs; patent issues related to vaccine development; implementation of PEPFAR; appropriations for USAID R&D and funding for IAVI | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2009-07-06T11:01:24-04:00 | |
| 782511 | HOLLAND & KNIGHT LLP 6f9c4dff-ca22-43a5-8949-e001873efe7e | Q2 | HOLLAND & KNIGHT LLP | 18466 | BIOTECHNOLOGY INDUSTRY ORGANIZATION | 2009 | second_quarter | PHA | Issues relating to the biotechnology industry. | HOUSE OF REPRESENTATIVES,SENATE | 100000 | 0 | 0 | 2009-07-06T13:26:29-04:00 | |
| 783039 | RASKY PARTNERS, INC. cebd93fd-41af-44d1-a1ab-b30099be5505 | Q2 | RASKY PARTNERS, INC. | 297410 | ELI LILLY AND CO | 2009 | second_quarter | PHA | 1548 An Act to amend the public health service act to establish a pathway for the licensure of biosimilar biological products, and for other purposes | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2009-07-07T16:12:18-04:00 | |
| 783848 | INDEPENDENT PHARMACY COOPERATIVE b474014d-9db2-460f-aec2-e4942dd82766 | Q2 | INDEPENDENT PHARMACY COOPERATIVE | 313098 | INDEPENDENT PHARMACY COOPERATIVE | 2009 | second_quarter | PHA | Average Manufacturer Price Pharmacy Reimbursement S. 511 and H.R. 616 Access To Durable Medical Equipment Act Antitrust Laws Regarding Pharmacy Benefit Managers | Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2009-07-09T10:35:51-04:00 | |
| 783869 | THE KROGER CO. e41b258d-c626-4279-b2a3-9198fd6f26d9 | Q2 | THE KROGER CO. | 88212 | KROGER CO | 2009 | second_quarter | PHA | S 511 Access to Durable Medical Equipment Act | HOUSE OF REPRESENTATIVES,SENATE | 145000 | 0 | 0 | 2009-07-09T10:52:03-04:00 | |
| 784224 | PRIME THERAPEUTICS daa597b7-b5da-482d-b2fb-18b157e8fd0c | Q2 | PRIME THERAPEUTICS | 400339576 | PRIME THERAPEUTICS | 2009 | second_quarter | PHA | HR 1204 "Community Pharmacy Fairness Act of 2009" S._____ "Affordable Health Choices Act" Health care reform - follow-on biologics, pharmaceutical benefits, comparative effectiveness, public plan option, drug pricing, generic pharmaceuticals, Health IT, Medicare Part D, medicaid, Medicare Part D HR 1427/S 726 "Promoting Innovation and Access to Life-saving Medicine Act" HR 1548 "Pathway for Biosimilars Act" Medicare Part D | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office | 106701 | 0 | 0 | 2009-07-09T14:32:53-04:00 | |
| 785001 | MR. THEODORE (TED) JONES 600dd5ee-853a-4305-87fe-395718687003 | Q2 | MR. THEODORE (TED) JONES | 20926 | PHARMACEUTICAL RESEARCH AND MANUFACTURES OF AMERICA | 2009 | second_quarter | PHA | Trade Association for certain Pharmaceutical Companies | HOUSE OF REPRESENTATIVES,SENATE | 15000 | 0 | 0 | 2009-07-10T14:36:46-04:00 | |
| 786104 | JULIE PHILP 2d10c194-aea3-4db0-b37d-69a8994c9be8 | Q2 | JULIE PHILP | 400407928 | NATIONAL GRASSROOTS AND COMMUNICATION | 2009 | second_quarter | PHA | Medicare and Medicaid issues; antitrust exemption to allow independent pharmacists to negotiate with private insurers and pharmacy benefit managers. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2009-07-13T13:00:10-04:00 | |
| 786134 | THE ASSOCIATION OF COMMUNITY PHARMACISTS CONGRESSIONAL NETWORK 14a369d1-1bf6-4881-9efc-1d6b1b9f5092 | Q2 | THE ASSOCIATION OF COMMUNITY PHARMACISTS CONGRESSIONAL NETWORK | 309377 | ASSOCIATION OF COMMUNITY PHARMACISTS CONGRESSIONAL NETWORK | 2009 | second_quarter | PHA | Medicare and Medicaid issues relating to pharmacy and reimbursement; HR 1204, an antitrust exemption to allow independent pharmacies to negotiate with private insurers and pharmacy benefit managers. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2009-07-13T13:17:25-04:00 | ||
| 786467 | HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) 1a1a7b69-562c-49d9-b4ab-652ee8ed9e68 | Q2 | HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) | 28776 | HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA) | 2009 | second_quarter | PHA | Importation of prescription drugs (S. 525/S. 1232/H.R. 1298) Rx Pedigree Methamphetaine/Pseudoephedrine Regulation (S.256/H.R. 2923) Dextromethorphan Regulation (H.R. 1259/S. 1383) | Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 240000 | 0 | 0 | 2009-07-13T14:59:30-04:00 | |
| 786606 | MEHLMAN CONSULTING, INC. 883b65a9-6c82-4099-9e40-5a4bca8f65bb | Q2 | MEHLMAN CONSULTING, INC. | 284950 | MERCK AND CO INC | 2009 | second_quarter | PHA | Support efforts to ensure appropriate access to vaccines and preventive care. Issues related to Medicare, Medicaid, and State Children's Health Insurance Program Coverage. Issues related to The Implementation of the FDAAA of 2007. Issues relating to importation of prescription drugs. | Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2009-07-13T15:35:32-04:00 | |
| 786694 | APTIV, PLC 5f17db0e-af47-4666-a1d2-d1d211ab5210 | Q2 | APTIV, PLC | 49054 | APTIV PLC | 2009 | second_quarter | PHA | Accessibility of generic drugs e-prescriptions Medical IT | Commerce, Dept of (DOC),Defense Advanced Research Projects Agency (DARPA),Defense, Dept of (DOD),Energy, Dept of,Environmental Protection Agency (EPA),Federal Aviation Administration (FAA),Federal Motor Carrier Safety Administration,Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Aeronautics & Space Administration (NASA),Pension Benefit Guaranty Corporation (PBGC),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT),Transportation Security Administration (TSA) | 340000 | 0 | 0 | 2009-07-13T16:06:45-04:00 | |
| 786851 | BROWN RUDNICK LLP 3136baec-d2b3-4a5f-9647-d0a05410c229 | Q2 | BROWN RUDNICK LLP | 287895 | HEALTHCARE DISTRIBUTION ALLIANCE F/K/A HEALTHCARE DISTRIBUTION MANAGEMENT ASSOC | 2009 | second_quarter | PHA | S.525 & H.R. 1298 - Pharmaceutical Market Access and Drug Safety Act of 2009 | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2009-07-13T17:09:47-04:00 | |
| 786960 | PARRY, ROMANI, DECONCINI & SYMMS 50285d6d-14b1-4045-bf06-17d9455a0604 | Q2 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | AMERICAN ASSOCIATION FOR HEALTH FREEDOM | 2009 | second_quarter | PHA | Support of legislation and efforts to guarantee access by health professionals and patients to medications such as estriol and other compounded preparations. No specific legislation has been introduced yet. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2009-07-13T17:46:22-04:00 | |
| 787317 | DUTKO WORLDWIDE, LLC 14e6683e-1eb5-499f-a70a-8e52a5be9b59 | Q2 | DUTKO WORLDWIDE, LLC | 12868 | NEWAYS INTERNATIONAL | 2009 | second_quarter | PHA | Monitor legislation pertaining to dietary supplements and pharmaceuticals, particularly the Food Safety Modernization Act (S. 510). | Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2009-07-14T09:29:50-04:00 | |
| 787354 | EXPRESS SCRIPTS, INC. e2af8004-b6d9-451d-943a-792b0d39fea9 | Q2 | EXPRESS SCRIPTS, INC. | 294416 | EXPRESS SCRIPTS, INC. | 2009 | second_quarter | PHA | Items related to reverse settlement payments between manufacturers, HR 1706 Changing the definition of first-to-file between manufacturers, S 1315 Items related to oversight of the federal employees health benefit program and its pharmacy benefit | Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Defense, Dept of (DOD),Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE | 410000 | 0 | 0 | 2009-07-14T09:44:36-04:00 | |
| 787435 | INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) 58478eb4-cb5f-482c-bde9-a49472569896 | Q2 | INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) | 400337570 | INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) | 2009 | second_quarter | PHA | Pharmacy Issues as they related to compounding pharmacists and pharmacy services/governance. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2009-07-14T10:44:41-04:00 | ||
| 787679 | CAPITOL HILL CONSULTING GROUP 5ba147d5-40fb-4cce-ab06-4cc3e45f94f1 | Q2 | CAPITOL HILL CONSULTING GROUP | 72053 | PURDUE PHARMA LLP | 2009 | second_quarter | PHA | Controlled Drug Substances Act (21 USC 13) | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2009-07-14T12:21:26-04:00 | |
| 788195 | ATRIUM HEALTH-FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM 1cfd67fd-aa9c-454e-b930-08787824d33f | Q2 | ATRIUM HEALTH-FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM | 58534 | ATRIUM HEALTH - FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM | 2009 | second_quarter | PHA | H.R.444; S. 1239. To amend section 340B of the Public Health Service Act to revise and expand the drug discount program under that section to improve the provision of discounts on drug purchases for certain safety net providers, any language expanding 340B drug discounts to inpatient settings. | HOUSE OF REPRESENTATIVES,SENATE | 60129 | 0 | 0 | 2009-07-14T15:33:25-04:00 | |
| 788878 | POLICY ADVOCATES 24cd928b-ec83-4772-b635-202b7425e939 | Q2 | POLICY ADVOCATES | 72018 | PHOENIX CAPITAL MANAGEMENT LLC | 2009 | second_quarter | PHA | Track and monitor Internet Pharmacy Issues. | HOUSE OF REPRESENTATIVES,SENATE | 17500 | 0 | 0 | 2009-07-15T09:10:00-04:00 | |
| 788973 | SQUIRE PATTON BOGGS 0455782c-d67f-4729-a89f-d4c83d8ce54d | Q2 | SQUIRE PATTON BOGGS | 30906 | KERR CORPORATION | 2009 | second_quarter | PHA | Issues related to FDA enforcement action against counterfeits of client's medical devices. | HOUSE OF REPRESENTATIVES | 0 | 0 | 2009-07-15T09:54:43-04:00 | ||
| 789046 | POLICY DIRECTIONS INC. fb093aee-4aef-41c6-b000-72a9e3196454 | Q2 | POLICY DIRECTIONS INC. | 31747 | ALPHARMA INC/PFIZER ANIMAL HEALTH (FORMERLY KNOWN AS ALPHARMA INC ) | 2009 | second_quarter | PHA | Antibiotics in animal foods Drug approvals Implementation of: All titles, to end the use of certain antibiotics in animal feed if those antibiotics are used in human medicine. S. 619/HR 1549, all titles, to require the manufacturers of antibiotics used in animal feed to make certain reports to FDA. Legislation to reform FDA regulation of federal imported and domestic food safety with emphasis on those titles related to the import of ingredients for food and drugs, as well as country-of-origin labeling. Monitor legislative and regulatory developments related to the Animal Drug User Fee Act reauthorization, with related developments of the Generic Animal Drug UserFee Act. Monitor developments of the Food & Drug Administrations development of its Advanced Feed Safety System related to the use of animal drugs in livestock and poultry feeds. | Agriculture, Dept of (USDA),Energy, Dept of,Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2009-07-15T10:21:26-04:00 | |
| 789883 | PRICEWATERHOUSECOOPERS 96b19b1f-38cd-4041-b9b4-e2a840bdde23 | Q2 | PRICEWATERHOUSECOOPERS | 10764 | SCHERING-PLOUGH CORPORATION | 2009 | second_quarter | PHA | General issues affecting pharmaceutical companies | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2009-07-15T13:14:28-04:00 | |
| 790037 | UNIVERSITY OF CONNECTICUT 6a0a50f9-2690-462a-a2ca-069df5ac4111 | Q2 | UNIVERSITY OF CONNECTICUT | 39382 | UNIVERSITY OF CONNECTICUT | 2009 | second_quarter | PHA | H.R.2997, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2010, FDA salaries and expenses; and extramural research related issues. Public Law 111-8, Omnibus Appropriations Act, FY2009, FDA salaries and expenses; and extramural research related issues. | Agriculture, Dept of (USDA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Oceanic & Atmospheric Administration (NOAA),SENATE,Small Business Administration (SBA) | 60000 | 0 | 0 | 2009-07-15T13:59:32-04:00 | |
| 790182 | EVERGREEN ASSOCIATES, LTD. 8ac718fb-6313-4a6f-aae5-1399413e4ab8 | Q2 | EVERGREEN ASSOCIATES, LTD. | 13984 | PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION | 2009 | second_quarter | PHA | Risk Communications: Consumer Medication Information, Medication Guides, Patient Package Inserts, Professional Inserts | Food & Drug Administration (FDA) | 0 | 0 | 2009-07-15T14:28:46-04:00 | ||
| 790745 | HANCE SCARBOROUGH 31c39ee9-6169-4e00-93ae-8c08003c4f1b | 2T | HANCE SCARBOROUGH | 17443 | ALLIANCE FOR PHARMACY COMPOUNDING | 2009 | second_quarter | PHA | Federal legislation affecting the practice of pharmacy and FDA regulation of compounded drugs. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 1 | 2009-07-15T16:09:20-04:00 | |
| 791433 | RUBICON ADVISORS, LLC 284fb9b0-8973-4e75-8dd7-4e8e3bc61969 | Q2 | RUBICON ADVISORS, LLC | 315091 | INSMED INCORPORATED | 2009 | second_quarter | PHA | Generic Biologics S. 1695 Affordable Health Care Choices Act | 22500 | 0 | 0 | 2009-07-15T20:18:42-04:00 | ||
| 791435 | RUBICON ADVISORS, LLC 71eaaec8-bae2-44ca-af76-c953f1274a66 | Q2 | RUBICON ADVISORS, LLC | 315091 | OSMOTICA PHARMACEUTICALS | 2009 | second_quarter | PHA | FDA Citizen Petition Reform Affordable Health Choices Act | 35000 | 0 | 0 | 2009-07-15T20:21:43-04:00 | ||
| 791436 | RUBICON ADVISORS, LLC 7d6025fa-6229-4b15-961a-d5336131f881 | Q2 | RUBICON ADVISORS, LLC | 315091 | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. | 2009 | second_quarter | PHA | Physician Payment Sunshine Act S. 2029 Patent Settlements H.R. 1432S. 316 Affordable Health Choices Act | 30000 | 0 | 0 | 2009-07-15T20:23:44-04:00 | ||
| 791437 | RUBICON ADVISORS, LLC a724b917-2f66-4973-911c-53b77c024e98 | Q2 | RUBICON ADVISORS, LLC | 315091 | GILEAD SCIENCES | 2009 | second_quarter | PHA | H.R. 822, H.R. 1943, H.R. 6114, S-2969 | 75000 | 0 | 0 | 2009-07-15T20:24:45-04:00 | ||
| 791438 | RUBICON ADVISORS, LLC 971b1128-e9a6-4588-8da3-7aacc12dfae0 | Q2 | RUBICON ADVISORS, LLC | 315091 | TEVA PHARMACEUTICALS USA | 2009 | second_quarter | PHA | Patent Settlements H.R. 1432 S. 316, Generic Biologics S. 1695 H.R. 5629, Physician Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affordable Health Choices Act | 105000 | 0 | 0 | 2009-07-15T20:26:46-04:00 | ||
| 791439 | RUBICON ADVISORS, LLC 76f83f2e-296d-4566-a792-11d9c50640d0 | Q2 | RUBICON ADVISORS, LLC | 315091 | WATSON PHARMACEUTICALS INC | 2009 | second_quarter | PHA | Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S. 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S. 2029 | 98000 | 0 | 0 | 2009-07-15T20:28:47-04:00 | ||
| 791676 | VAN SCOYOC ASSOCIATES b0e8f5ba-1483-4010-99cb-099ed17cc01e | Q2 | VAN SCOYOC ASSOCIATES | 39837 | UNIVERSITY OF CONNECTICUT | 2009 | second_quarter | PHA | H.R.2997, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2010, FDA salaries and expenses; and extramural research related issues. Public Law 111-8, Omnibus Appropriations Act, FY2009, FDA salaries and expenses; and extramural research related issues. | Agriculture, Dept of (USDA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Oceanic & Atmospheric Administration (NOAA),SENATE,Small Business Administration (SBA) | 50000 | 0 | 0 | 2009-07-16T07:51:16-04:00 | |
| 791692 | VAN SCOYOC ASSOCIATES 7a3d16a7-bb0e-443d-b539-f0e6afc3b29d | Q2 | VAN SCOYOC ASSOCIATES | 39837 | UNIVERSITY OF PENNSYLVANIA SCHOOL OF MEDICINE | 2009 | second_quarter | PHA | H.R.2997, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2010, FDA and USDA funding initiatives. Public Law 111-8, Omnibus Appropriations Act, FY2009, FDA and USDA funding initiatives. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2009-07-16T07:52:18-04:00 | |
| 791705 | VAN SCOYOC ASSOCIATES e2a303b2-cc61-4b29-9325-15ccc9756bf7 | Q2 | VAN SCOYOC ASSOCIATES | 39837 | UNIVERSITY OF MARYLAND BALTIMORE | 2009 | second_quarter | PHA | H.R.2997, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2010, FDA salaries and expenses; and extramural research related issues. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2009-07-16T08:38:25-04:00 | |
| 792009 | THE UNITED STATES PHARMACOPEIAL CONVENTION 6b4f3512-3f86-42ac-ab41-8c40a18fc2ed | Q2 | THE UNITED STATES PHARMACOPEIAL CONVENTION | 400358632 | THE UNITED STATES PHARMACOPEIAL CONVENTION | 2009 | second_quarter | PHA | -HR 1859/ S 767, "Independent Drug Education & Outreach Act", regarding all provisions, specifically standards relating to academic detailing. -HR 1427/S 726, "Promoting Innovation and Access to Lifesaving Medicine Act, regarding all provisions. -HR 1548, "Pathway for Biosimilars Act", regarding all provisions. -HR 1298/ S 525, "Pharmaceutical Market Access and Drug Safety Act of 2009", regarding all provisions in supporting the FDA and compendial standards for drugs (reimportation and importation). -Issues relating to Heparin, consultation on heparin and compendial standards. -S 882, "Drug and Device Accountability Act of 2009", regarding section 111 in support of compedial modernization. -S 369, "The Preserving Access to Affordable Generic Drugs Act", regarding all provisions. -Consultation regarding exclusivity in drug law. -Information regarding USP General Chapter <1> Injections - labeling on ferrules and cap overseals. -Outreach to House and Senate staff to explain USP's standards setting mission. -Outreach to Administration to explain USP's standards setting mission. -Communications with Congress regarding USP China MOU re: drugs. | Congressional Budget Office (CBO),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,President of the U.S.,SENATE | 80000 | 0 | 0 | 2009-07-16T09:53:33-04:00 | |
| 792106 | VENABLE LLP 9ee0d817-e398-4f20-9371-c973d28ef127 | Q2 | VENABLE LLP | 39941 | ENDO PHARMACEUTICALS INC | 2009 | second_quarter | PHA | General issues affecting the pharmaceutical industry. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2009-07-16T10:10:07-04:00 | |
| 792133 | LONG TERM CARE PHARMACY ALLIANCE 5dac0aff-e115-4515-b222-2f9d657b534a | Q2 | LONG TERM CARE PHARMACY ALLIANCE | 400309443 | LONG TERM CARE PHARMACY ALLIANCE | 2009 | second_quarter | PHA | Medicare Part D | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 201000 | 0 | 0 | 2009-07-16T10:17:22-04:00 | |
| 792178 | LATHAM & WATKINS LLP efa8a605-72d5-4ef6-968b-67d7bc16f7b7 | Q2 | LATHAM & WATKINS LLP | 22201 | ORCHID CHEMICALS & PHARMACEUTICALS LTD | 2009 | second_quarter | PHA | Food and Drug Administration policy. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2009-07-16T10:25:10-04:00 | |
| 792598 | CAPITOL COUNSEL LLC 02447af4-8061-4007-a5a6-61f398f4c27e | Q2 | CAPITOL COUNSEL LLC | 313715 | CARDINAL HEALTH INC | 2009 | second_quarter | PHA | Issues related to pharmaceutical supply chain and distribution,including federal pedigree | HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2009-07-16T11:41:02-04:00 | |
| 792725 | AMERICAN COLLEGE OF CLINICAL PHARMACY 5fcdca33-c215-41c4-87ba-278ffad0841f | Q2 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 57258 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 2009 | second_quarter | PHA | Coverage for direct patient care services of qualified pharmacists under Medicare Part B and other public health programs. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 60700 | 0 | 0 | 2009-07-16T12:01:51-04:00 | |
| 792833 | ASSOCIATION FOR ACCESSIBLE MEDICINES 3643f1dc-374e-4143-9f18-321efc7b1e8c | Q2 | ASSOCIATION FOR ACCESSIBLE MEDICINES | 16032 | ASSOCIATION FOR ACCESSIBLE MEDICINES | 2009 | second_quarter | PHA | Generic Biologics, including but not limited to: H.R.1427, H.R.1548, and S.726 Prescription Drug Safety Counterfeit Drugs/Import Safety/Pedigree, such as: H.R.759 Authorized Generics, including, but not limited to: S.501 and H.R.573 Prescription Drug Importation/Re-Importation Any other matters that relate to access to generic drugs | Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Congressional Budget Office (CBO),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,U.S. Trade Representative (USTR),White House Office | 570363 | 0 | 0 | 2009-07-16T12:21:02-04:00 | |
| 793319 | FOOD MARKETPLACE INC. a7f77929-add4-48df-855d-e2bb0b36c915 | Q2 | FOOD MARKETPLACE INC. | 15097 | FOOD MARKETPLACE INC | 2009 | second_quarter | PHA | HR 616 and S. 511, Access to Durable Medical Equipment Act, to amend part B of title XVIII of the Social Security Act to provide for an exemption of pharmacies and pharmacists from certain Medicare accreditation requirements in the same manner as such exemption applied to certain professionals; exempts pharmacists and pharmacies from accreditation requirements in the Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies program. S. 256, Combat Methamphetamine Enhancement Act of 2009, letter sent to Sen. Feinstein (D-CA) in support of entire bill. No bill number yet, Senate Health, Education, Lobor and Pension Committee's Affordable Health Choices Act - lobbied Section 213 and 212 of the Act in support of pharmacist provided MTM services and medical home House Tri-Committee Health Care Reform Legislation - Discussion Draft, Section 1841, Pages 708 - 710 - AMP Medicaid Reimbursement Formula. HR 1970 - Preserve Patient Access to Reputable DMEPOS Providers Act, support full text. HR 616 - Access to Durable Medical Equipment Act, support full text. S. 511 - Access to Durable Medical Equipment Act, support full text. | Federal Reserve System,HOUSE OF REPRESENTATIVES,SENATE | 1116360 | 0 | 0 | 2009-07-16T13:55:53-04:00 | |
| 793419 | WALMART INC. d25339b8-2e07-4f72-bb2f-59e80f1b511e | Q2 | WALMART INC. | 40305 | WALMART INC | 2009 | second_quarter | PHA | H.R. 1548 & S. 1427 to amend title XIX of the Society Security Act to ensure that individuals eligible for medical assistance under the Medicaid Program continue to have access to prescription drugs, and for other purposes Average Manufacturers Price H.R. 616 & S. 511 to amend part B of title XVIII of the Social Security Act to provide for an exemption of pharmacies and pharmacists from certain Medicare accreditation requirements in the same manner as such exemption applies to certain professionals H.R. 1970 & S. 956 to amend title XVIII of the Social Security Act to exempt unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) | Agriculture, Dept of (USDA),Commerce, Dept of (DOC),Consumer Product Safety Commission (CPSC),Council on Environmental Quality (CEQ),Energy, Dept of,Federal Energy Regulatory Commission (FERC),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Economic Council (NEC),Natl Security Council (NSC),Office of Natl Drug Control Policy (NDCP),SENATE,State, Dept of (DOS),Treasury, Dept of,U.S. Customs & Border Protection,U.S. Trade Representative (USTR),White House Office | 2580000 | 0 | 0 | 2009-07-16T14:14:52-04:00 | |
| 793610 | MASSACHUSETTS MEDICAL SOCIETY ae64ba7c-f8ec-4895-acd3-8189488c22de | Q2 | MASSACHUSETTS MEDICAL SOCIETY | 23975 | MASSACHUSETTS MEDICAL SOCIETY | 2009 | second_quarter | PHA | S. 301, Physician Payment Sunshine Act legislation which would require pharmaceutical companies and device manufactures to disclosure gifts and other contributions to physicians HR 1427/S 726 Providing Innovative Access to Life Saving Medicines Act Health Care Reform - Proposals to eliminate tax deductibility for direct to consumer advertising | Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2009-07-16T14:47:48-04:00 | |
| 793623 | EISAI INC. 5473fcc5-ea90-40c3-896d-3ad3e3af1eca | Q2 | EISAI INC. | 400321512 | EISAI INC. | 2009 | second_quarter | PHA | Biosimilars, Follow-on biologics H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 Pathway for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act S. 301 Physician Payments Sunshine Act of 2009 | HOUSE OF REPRESENTATIVES,SENATE | 570000 | 0 | 0 | 2009-07-16T14:50:54-04:00 | |
| 793725 | THE OB-C GROUP, LLC d05b610f-6f7c-4d26-afe9-7e211d37ced7 | Q2 | THE OB-C GROUP, LLC | 29802 | ELI LILLY | 2009 | second_quarter | PHA | HR 1548, Pathway for Biosimilars Act: entire bill. No specific bill number: matters relating to pharmaceutical manufacturers in Health Care Reform. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2009-07-16T15:05:15-04:00 | |
| 793952 | AVENUE SOLUTIONS 0f78db50-8a54-4905-94d2-c69e465f42bf | Q2 | AVENUE SOLUTIONS | 72111 | AETNA | 2009 | second_quarter | PHA | Senate HELP Committee Draft Affordable Health Choices Act (Kennedy) - generic biologics; H.R. 1204, Community Pharmacy Fairness Act (Weiner) - antitrust exemption for pharmacies; H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act (Waxman) - generic biologics; H.R. 1548, Pathway for Biosimilars Act (Eshoo) - generic biologics; H.R. 1706, Protecting Consumer Access to Generic Drugs Act (Rush) generic drugs; S. 369, Preserve Access to Affordable Generics Act (Kohl) generic drugs; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act (Schumer) generic biologics. | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office | 60000 | 0 | 0 | 2009-07-16T15:46:23-04:00 | |
| 793961 | AVENUE SOLUTIONS 5ec6d7c6-a62d-45c0-83e2-444e2b22e699 | Q2 | AVENUE SOLUTIONS | 72111 | BLUE CROSS BLUE SHIELD ASSOCIATION | 2009 | second_quarter | PHA | Senate HELP Committee Draft Affordable Health Choices Act (Kennedy) - generic biologics; H.R. 1204, Community Pharmacy Fairness Act (Weiner) - antitrust exemption for pharmacies; H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act (Waxman) - generic biologics; H.R. 1548, Pathway for Biosimilars Act (Eshoo) - generic biologics; H.R. 1706, Protecting Consumer Access to Generic Drugs Act (Rush) generic drugs; S. 369, Preserve Access to Affordable Generics Act (Kohl) generic drugs; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act (Schumer) generic biologics. | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office | 80000 | 0 | 0 | 2009-07-16T15:46:30-04:00 | |
| 793986 | AVENUE SOLUTIONS 2d86c89f-75e4-4358-b0e7-1d7ce9c73209 | Q2 | AVENUE SOLUTIONS | 72111 | HEALTHCARE LEADERSHIP COUNCIL | 2009 | second_quarter | PHA | Senate HELP Committee Draft Affordable Health Choices Act (Kennedy) - generic biologics; H.R. 1204, Community Pharmacy Fairness Act (Weiner) - antitrust exemption for pharmacies; H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act (Waxman) - generic biologics; H.R. 1548, Pathway for Biosimilars Act (Eshoo) - generic biologics; H.R. 1706, Protecting Consumer Access to Generic Drugs Act (Rush) generic drugs; S. 369, Preserve Access to Affordable Generics Act (Kohl) generic drugs; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act (Schumer) generic biologics. | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office | 60000 | 0 | 0 | 2009-07-16T15:49:39-04:00 | |
| 793996 | AVENUE SOLUTIONS 0a77c40d-be47-4a37-b8b8-f49eadefe9df | Q2 | AVENUE SOLUTIONS | 72111 | EXPRESS SCRIPTS INC | 2009 | second_quarter | PHA | Senate HELP Committee Draft Affordable Health Choices Act (Kennedy) generic biologics; H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act (Waxman) generic biologics; H.R. 1548, Pathway for Biosimilars Act (Eshoo) generic biologics; H.R. 1706, Protecting Consumer Access to Generic Drugs Act (Rush) generic drugs; S. 369, Preserve Access to Affordable Generics Act (Kohl) generic drugs; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act (Schumer) generic biologics. | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office | 80000 | 0 | 0 | 2009-07-16T15:50:46-04:00 | |
| 794022 | AVENUE SOLUTIONS 110e150d-6353-4659-a02c-35c5891cf64f | Q2 | AVENUE SOLUTIONS | 72111 | UNITEDHEALTH GROUP INC | 2009 | second_quarter | PHA | Senate HELP Committee Draft Affordable Health Choices Act (Kennedy) - generic biologics; H.R. 1204, Community Pharmacy Fairness Act (Weiner) - antitrust exemption for pharmacies; H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act (Waxman) - generic biologics; H.R. 1548, Pathway for Biosimilars Act (Eshoo) - generic biologics; H.R. 1706, Protecting Consumer Access to Generic Drugs Act (Rush) generic drugs; S. 369, Preserve Access to Affordable Generics Act (Kohl) generic drugs; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act (Schumer) generic biologics. | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office | 60000 | 0 | 0 | 2009-07-16T15:53:00-04:00 | |
| 794211 | PARRY, ROMANI, DECONCINI & SYMMS 75931ae7-5d6b-4658-b454-55fb7269b650 | Q2 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | SUNOVION PHARMACEUTICALS INC (FORMERLY SEPRACOR INC ) | 2009 | second_quarter | PHA | No specific legislation or bills introduced at this time. Medicare reimbursement issues. | HOUSE OF REPRESENTATIVES,SENATE | 45000 | 0 | 0 | 2009-07-16T16:27:04-04:00 | |
| 794244 | FABIANI & COMPANY 10c785e8-7339-4959-a8e6-772e20d8d3f1 | Q2 | FABIANI & COMPANY | 72576 | ALNYLAM PHARMACEUTICALS | 2009 | second_quarter | PHA | S.515 Patent Reform Act Provisions relating to the apportionment of damages | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2009-07-16T16:31:58-04:00 | |
| 794333 | TEVA PHARMACEUTICALS USA, INC. 31753018-5dcf-4e63-8003-561f638953f8 | Q2 | TEVA PHARMACEUTICALS USA, INC. | 76695 | TEVA PHARMACEUTICALS USA INC | 2009 | second_quarter | PHA | S. 301, Physician Payments Sunshine Act of 2009; H.R. 1859 and S. 767, Independent Drug Education and Outreach Act of 2009; H.R. 1427 and S. 726, Promoting Innovation and Access to Life-Saving Medicine Act; and H.R. 1548, Pathway for Biosimilars Act; legislation and proposals relating to "doughnut hole" impact; and FDA implementation of the Food & Drug Administration Amendments Act ("FDAAA"). | Commerce, Dept of (DOC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Patent & Trademark Office (PTO),SENATE,U.S. Trade Representative (USTR) | 840000 | 0 | 0 | 2009-07-16T16:48:42-04:00 | |
| 794511 | US STRATEGIES d2f6c8dc-a633-490f-a532-f2ca72265d59 | Q2 | US STRATEGIES | 38825 | NOVOLOGIX (FORMERLY ANCILLARY CARE MANAGEMENT) | 2009 | second_quarter | PHA | Medicare and Medicaid provisions relating to pharmacy and medication management policies | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2009-07-16T17:18:28-04:00 | |
| 794687 | CENCORA, INC. 1cbd0723-9a91-4752-b289-1607ae1981f7 | Q2 | CENCORA, INC. | 293756 | CENCORA, INC. | 2009 | second_quarter | PHA | H.R. 1392 and S. 1221, legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. | HOUSE OF REPRESENTATIVES,SENATE | 226700 | 0 | 0 | 2009-07-16T17:44:38-04:00 | |
| 794709 | PODESTA GROUP, INC. a44743f4-f424-4510-a63c-4501c159c087 | Q2 | PODESTA GROUP, INC. | 31680 | GENENTECH | 2009 | second_quarter | PHA | H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 Pathway for Biosimilars Act of 2009 S. 726 Promoting Innovation and Access to Life-Saving Medicine Act | Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2009-07-16T17:50:46-04:00 | |
| 794791 | PODESTA GROUP, INC. 54fbdc94-5ca9-4d76-8a64-4d3bf92a641a | Q2 | PODESTA GROUP, INC. | 31680 | THE UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER | 2009 | second_quarter | PHA | Patient safety, animal research, clinical trials, scientific misconduct, conflict of interest S. 717 21st Century Cancer ALERT (Access to Life Saving Early detection, Research and Treatment) Act | HOUSE OF REPRESENTATIVES,SENATE | 110000 | 0 | 0 | 2009-07-16T18:04:31-04:00 | |
| 794831 | PODESTA GROUP, INC. 7462969f-5705-4b8a-a024-b879923ced73 | Q2 | PODESTA GROUP, INC. | 31680 | WINNING STRATEGIES WASHINGTON LLC | 2009 | second_quarter | PHA | Medicare, Durable Equipment, Prosthetics, Orthotics and Supplies - Competitive Bidding Program Issues Kennedy Healthcare Reform Bill House Tri Committee Healthcare Reform Bill Tri Caucus Healthcare Reform Bill Senate Finance Healthcare Reform Bill H.R. 616 Pharmacists Exemption to CMS DME Requirements | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2009-07-16T18:11:48-04:00 | |
| 795464 | THE RUSSELL GROUP, INC. f4ba6722-1cc6-43be-a4a9-0d478c8e0fa0 | Q2 | THE RUSSELL GROUP, INC. | 22688 | GENERIC PHARMACEUTICAL ASSOCIATION | 2009 | second_quarter | PHA | Issues relative to generic pharmaceuticals and generic biologics; H.R. 2997, S. 1406 - 2010 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill (Title VI - Related Agencies and Food and Drug Administration Department of Health and Human Services); H.R. 1427, S. 726 - Promoting Innovation and Access to Life-Saving Medicine Act (entire bill) | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2009-07-17T09:03:09-04:00 | |
| 795599 | ANIMAL HEALTH INSTITUTE 351dfa52-f53b-46ca-a5fd-55b01db2db06 | Q2 | ANIMAL HEALTH INSTITUTE | 4037 | ANIMAL HEALTH INSTITUTE | 2009 | second_quarter | PHA | Antimicrobial Resistance; HR 1549, S619, Preservation of Antibiotics for Medical Treatment Act; HR2400, Strategies to Address Antimicrobial Resistance Act; S510, FDA Food Safety Modernization Act; HR2749, Food Safety Enhancement Act of 2009 | Agriculture, Dept of (USDA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2009-07-17T09:24:59-04:00 | |
| 795994 | PARRY, ROMANI, DECONCINI & SYMMS 15204b09-19f3-464f-bb1c-ee5a7e42d275 | Q2 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | BRAIDWOOD MANAGEMENT, INC. | 2009 | second_quarter | PHA | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2009-07-17T10:33:49-04:00 | |
| 796092 | MOFFETT GROUP, LLC 798078c7-1349-4e25-ad16-b40e3179bacc | Q2 | MOFFETT GROUP, LLC | 82578 | BOEHRINGER INGELHEIM PHARMECEUTICAL | 2009 | second_quarter | PHA | Phamaceutical issues, especially with respect to the House Energy and Commerce Committee. | HOUSE OF REPRESENTATIVES,SENATE | 38568 | 0 | 0 | 2009-07-17T10:48:53-04:00 | |
| 796104 | AMYLIN PHARMACEUTICALS 45b0dc17-9bda-4fad-a06a-2036b6e82f28 | Q2 | AMYLIN PHARMACEUTICALS | 308536 | AMYLIN PHARMACEUTICALS | 2009 | second_quarter | PHA | Payment disclsoure regulations in the Physician Payments Sunshine Act of 2009 Data exclusivity provisions in H.R. 1548, Pathway for Biosimilars Act Data eclsuivity provisions in Promoting Innovation and Access to Life-Saving Medicine Act (H.R. 1427,S. 726) Regulatory provisions in the Food and Drug Administration Globalization Act of 2009 (H.R. 759) Drug Importation/Drug Safety | Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 320000 | 0 | 0 | 2009-07-17T10:50:00-04:00 | |
| 796155 | AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 30d2bf75-8754-44a9-b75e-34c866c68ee0 | Q2 | AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | 3457 | AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | 2009 | second_quarter | PHA | Communication with FDA and HHS regarding standards for securing the drug supply chain and the National Drug Code system. Communication with the Office of the National Coordinator regarding "Draft Use of Electronic Health Records in Clinical Research. Communication with Food and Drug Administration on evaluation of consumer medication information. Communication with Health Resources and Services Administration on National Quality Forum priorities and pharmacist residency training and workforce issues. Comments to Office of the National Coordinator regarding health information technology extension program. Communication with Drug Enforcement Administration regarding implementation of Ryan Haight Online Pharmacy Consumer Protection Act of 2008. Communication with Centers for Medicare and Medicaid Services regarding anticoagulation clinic billing issue. | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Environmental Protection Agency (EPA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE,White House Office | 250000 | 0 | 0 | 2009-07-17T10:55:12-04:00 | |
| 796222 | JOHNS HOPKINS UNIVERSITY e21c8f48-a2e8-4492-ba47-a559a2888f5d | Q2 | JOHNS HOPKINS UNIVERSITY | 20664 | JOHNS HOPKINS UNIVERSITY | 2009 | second_quarter | PHA | H.R.444: 340B Program Improvement and Integrity Act of 2009. Issues regarding extending 340B outpatient pharmaceutical discount to the inpatient setting. | HOUSE OF REPRESENTATIVES,SENATE | 230000 | 0 | 0 | 2009-07-17T11:04:33-04:00 | |
| 796393 | PARRY, ROMANI, DECONCINI & SYMMS ecbfb0bb-5987-44d6-b58b-d86e7781bca1 | Q2 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | INTL ACADEMY OF COMPOUNDING PHARMACISTS | 2009 | second_quarter | PHA | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. | HOUSE OF REPRESENTATIVES,SENATE | 15000 | 0 | 0 | 2009-07-17T11:23:23-04:00 | |
| 796653 | KNIGHT CAPITOL CONSULTANTS 3f1fab9a-f61a-4960-a863-2c057b9a4b60 | Q2 | KNIGHT CAPITOL CONSULTANTS | 40036301 | SANOFI US SERVICES INC (FORMERLY KNOWN AS "SANOFI-AVENTIS U S INC ) | 2009 | second_quarter | PHA | Adequacy of Appropriations for the Food and Drug Administration (S. 1406) | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2009-07-17T11:58:16-04:00 | |
| 796727 | AARP 70494fea-7c0c-40eb-adbe-98714651857b | Q2 | AARP | 1694 | AARP | 2009 | second_quarter | PHA | S.525/H.R. 1298, Pharmaceutical Market Access and Drug Safety Act of 2009 - Discussed legislation which would create a system of safe importation of prescription drugs from abroad. S.726/H.R.1427, Promoting Innovation and Access to Life-Saving Medicine Act - Discussed legislation which would create a pathway for the approval of safe, effective biosimilar and generic biologic drugs. H.R.1706, Protecting Consumer Access to Generic Drugs Act of 2009 - Discussed legislation that would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes. S. 369, Preserve Access to Affordable Generics Act - Discussed legislation that would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market,and for other purposes. S.515/H.R.1260, Patent Reform Act of 2009 - Discussed legislation that would amend federal patent law to rewrite provisions concerning the conditions for patentability. Specifically, AARP weighed in on the inequitable conduct provisions of the legislation. S. 301, Physician Payments Sunshine Act of 2009 - Discussed legislation that would provide for disclosure of gifts given by pharmaceutical and device manufacturers to physicians. H.R.2997 Agriculture, Rural Development, FDA and related agencies Appropriations bill for FY2010-Lobbied in support of funding for the Commodity Supplemental Food Program and FDA Office of Generic Drugs, rural housing assistance and repair. | Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Energy, Dept of,Federal Communications Commission (FCC),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Internal Revenue Service (IRS),Labor, Dept of (DOL),Office of Management & Budget (OMB),Office of the Vice President of the United States,Securities & Exchange Commission (SEC),SENATE,Social Security Administration (SSA),Transportation, Dept of (DOT),Treasury, Dept of,White House Office | 5300000 | 0 | 0 | 2009-07-17T12:05:18-04:00 | |
| 796755 | DLA PIPER LLP (US) 4e22dd7c-df81-4dbe-ba73-4c3a54e8cbb0 | Q2 | DLA PIPER LLP (US) | 76855 | SANOFI PASTEUR | 2009 | second_quarter | PHA | Pandemic influenza, biodefense, and other vaccine-related issues. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2009-07-17T12:07:32-04:00 | |
| 796789 | ASSOCIATION OF NATIONAL ADVERTISERS, INC. d2980662-c527-4e81-bf39-f6803e56f295 | Q2 | ASSOCIATION OF NATIONAL ADVERTISERS, INC. | 4653 | ASSOCIATION OF NATIONAL ADVERTISERS, INC. | 2009 | second_quarter | PHA | Proposals to place a moratorium on prescription drug advertising and requiring a "fair balance" between risk and benefit information in prescription drug advertisements Proposals to extend FDA authority to over-the-counter drug advertisements | Federal Communications Commission (FCC),Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE | 240000 | 0 | 0 | 2009-07-17T12:12:58-04:00 | |
| 796984 | TARPLIN, DOWNS & YOUNG, LLC a54422aa-7e30-47ba-9c38-973b65d3529b | Q2 | TARPLIN, DOWNS & YOUNG, LLC | 304736 | BIOTECHNOLOGY INDUSTRY ORGANIZATION | 2009 | second_quarter | PHA | ** see addendum page Import Safety H.R. 759 - Food and Drug Administration Globalization Act of 2009 S. 510 - FDA Food Safety Modernization Act Importation S. 525/H.R. 1298 - Pharmaceutical Market Access and Drug Safety Act of 2009 S. 80 - Pharmaceutical Market Access Act of 2009 ***, no specific bill(s), Drug Safety, Prescription Drug Importation, Import Safety | HOUSE OF REPRESENTATIVES,SENATE,White House Office | 70000 | 0 | 0 | 2009-07-17T12:35:02-04:00 | |
| 797083 | PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION d0fdaedd-5785-4b6e-92eb-2dcc8e843a81 | Q2 | PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION | 31348 | PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION | 2009 | second_quarter | PHA | H.R. 1204 - Community Pharmacy Fairness Act Electronic Prescribing Mail Order Pharmacy | Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Federal Trade Commission (FTC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),SENATE | 250327 | 0 | 0 | 2009-07-17T12:47:35-04:00 | |
| 797210 | PARRY, ROMANI, DECONCINI & SYMMS 9a0f48f4-d93f-4bc8-815f-4d2356c0bf98 | Q2 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | VETERINARY PHARMACIES OF AMERICA, INC. | 2009 | second_quarter | PHA | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2009-07-17T12:58:29-04:00 | |
| 797337 | PARRY, ROMANI, DECONCINI & SYMMS 615bb9ea-6e96-4d33-9ae9-c2720e1121f5 | Q2 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | WEDGEWOOD VILLAGE PHARMACY, INC. | 2009 | second_quarter | PHA | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2009-07-17T13:10:07-04:00 | |
| 797405 | KIRKLAND & ELLIS LLP 8f91d315-a1aa-4994-9d2f-d06a2cc372b1 | Q2 | KIRKLAND & ELLIS LLP | 21745 | TEVA PHARMACEUTICALS USA | 2009 | second_quarter | PHA | House and Senate legislation on biologic medicines. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2009-07-17T13:17:32-04:00 | ||
| 797409 | PARRY, ROMANI, DECONCINI & SYMMS c0a08309-cb5c-41e6-864f-0a801a57664c | Q2 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | WOMEN'S INTERNATIONAL PHARMACY, INC. | 2009 | second_quarter | PHA | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2009-07-17T13:18:34-04:00 | |
| 797467 | TARPLIN, DOWNS & YOUNG, LLC 2e9b9170-4e08-4901-b405-f197972ed27e | Q2 | TARPLIN, DOWNS & YOUNG, LLC | 304736 | HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) | 2009 | second_quarter | PHA | **see addendum page Importation of prescription drugs (S. 525/H.R. 1298/S. 1232) RX Pedigree Methamphetamine/Pseudoephedrine Regulation (S. 256/H.R. 2923) Dextromethorphan Regulaton (H.R. 1259/S. 1383) | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2009-07-17T13:26:15-04:00 | |
| 797701 | TARPLIN, DOWNS & YOUNG, LLC 7b05d455-46fd-40d2-9e64-a01b1a9542ef | Q2 | TARPLIN, DOWNS & YOUNG, LLC | 304736 | PHRMA | 2009 | second_quarter | PHA | **see addendum page Import Safety H.R. 759 - Food and Drug Administration Globalization Act of 2009 S. 510 - FDA Food Safety Modernization Act Importation S. 525/H.R. 1298 - Pharmaceutical Market Access and Drug Safety Act of 2009 S. 80 - Pharmaceutical Market Access Act of 2009 ***, no specific bill(s), prescription drug importation, import safety | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2009-07-17T13:48:50-04:00 | |
| 798002 | PD FRAZER CONSULTING, INC. 8666c1d6-fd15-49c3-935b-6e732a64f73b | Q2 | PD FRAZER CONSULTING, INC. | 65998 | CANADA INTERNATIONAL PHARMACY ASSOCIATION | 2009 | second_quarter | PHA | Monitor the development of proposed bills on the importation of prescription drugs | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2009-07-17T14:16:01-04:00 | |
| 798197 | MCDERMOTT WILL & SCHULTE LLP dc43dfad-3538-4154-9fc3-cd7285efe01f | Q2 | MCDERMOTT WILL & SCHULTE LLP | 24338 | RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION | 2009 | second_quarter | PHA | Amendments to Section 340B of the Public Health Service Act to gain eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program; seeking to advance H.R. 444. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2009-07-17T14:33:48-04:00 | |
| 798292 | INDEPENDENCE BLUE CROSS 9783509a-a2cb-495f-a8b3-9d0c8124de5e | Q2 | INDEPENDENCE BLUE CROSS | 19172 | INDEPENDENCE BLUE CROSS | 2009 | second_quarter | PHA | Biogenerics/Generic Biologies: HR1427 "Promoting Innovation and Access to Life-Saving Medicine Act" Carve out of FEBHBP Rx benefits | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2009-07-17T14:39:31-04:00 | ||
| 798329 | THE ACCORD GROUP 94376c49-e89b-49c7-95fd-0f32eb0ae692 | Q2 | THE ACCORD GROUP | 42785 | CITIZENS FOR SUN PROTECTION | 2009 | second_quarter | PHA | Final promulgation of FDA sunscreen monograph | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2009-07-17T14:43:53-04:00 | ||
| 798419 | THE DUBERSTEIN GROUP INC. 1496e54e-5d39-43f0-872e-46f86f3d94c8 | Q2 | THE DUBERSTEIN GROUP INC. | 12675 | AMERICA'S HEALTH INSURANCE PLANS | 2009 | second_quarter | PHA | Antitrust exemption for pharmacies - HR 1204, To ensure and foster continued patient safety and quality of care by making the antitrust laws apply to negotiations between groups of independent pharmacies and health plans and health insurance issuers (including health plans under parts C and D of the Medicare Program) in the same manner as such laws apply to protected activities under the National Labor Relations Act. Generic biologics - HR 1427, To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes; HR 1548, To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes; S 726, A bill to amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes; draft legislation re this issue (HELP/Kennedy Affordable Health Choices). Generic drugs - HR 1706, To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes; S 369, A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market. | HOUSE OF REPRESENTATIVES,SENATE | 100000 | 0 | 0 | 2009-07-17T14:52:39-04:00 | |
| 798505 | MCAPITOL MANAGEMENT 155c62e7-66ba-4a32-b14a-908b494abdbe | Q2 | MCAPITOL MANAGEMENT | 78471 | MINNESOTA THERMAL SCIENCE | 2009 | second_quarter | PHA | vaccines | HOUSE OF REPRESENTATIVES | 20000 | 0 | 0 | 2009-07-17T14:57:07-04:00 | |
| 798636 | THE DUBERSTEIN GROUP INC. cda69274-005c-4cdc-a976-b3b916053f1d | Q2 | THE DUBERSTEIN GROUP INC. | 12675 | SUPERVALU | 2009 | second_quarter | PHA | Healthcare reform and specifically pharmacy issues - Proposed legislation re these issues | Agriculture, Dept of (USDA),HOUSE OF REPRESENTATIVES,SENATE | 100000 | 0 | 0 | 2009-07-17T15:11:13-04:00 | |
| 798861 | ALCALDE & FAY bf929a4e-150f-458f-bf28-eb46f5aec1b9 | Q2 | ALCALDE & FAY | 818 | XSTREAM SYSTEMS, INC. | 2009 | second_quarter | PHA | Bringing awareness of the pharmaceutical authentication product to Committees of Congress and federal agencies; Seek to include an authentication provision in legislation addressing counterfeit drugs, pharmaceutical importation, and pharmaceutical distribution including H.R.1298, S.80, and S.525 | Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,Veterans Affairs, Dept of (VA) | 10000 | 0 | 0 | 2009-07-17T15:36:11-04:00 | |
| 798930 | FABIANI & COMPANY bd604ec7-d444-484b-8b83-f4d67317ca5e | Q2 | FABIANI & COMPANY | 72576 | ACORDA THERAPEUTICS, INC. | 2009 | second_quarter | PHA | Educate members and staff about Acordas products. Secure funding through the annual appropriation process for research. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2009-07-17T15:41:41-04:00 | |
| 799002 | TARPLIN, DOWNS & YOUNG, LLC ffd60242-896f-4b21-adff-627347584e3d | Q2 | TARPLIN, DOWNS & YOUNG, LLC | 304736 | WYETH | 2009 | second_quarter | PHA | **see addendum page Biosimilars S. 726/H.R. 1427 - Access to Life-Saving Medicine Act, Follow-on Biologics H.R. 1548 - the Pathway for Biosimilars Act Import Safety H.R. 759 - Food and Drug Administration Globalization Act of 2009 S. 510 - FDA Food Safety Modernization Act ***, no specific bill(s), Biosimilars, Drug Safety, Prescription Drug Importation, Import Safety, Compounding | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2009-07-17T15:47:56-04:00 | |
| 799018 | PODESTA GROUP, INC. 2181ffea-c41e-4457-a482-ccef97ed5c0a | Q2 | PODESTA GROUP, INC. | 31680 | BRISTOL-MYERS SQUIBB | 2009 | second_quarter | PHA | H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 Pathway for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act Drug Importation/Drug Safety | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2009-07-17T15:48:14-04:00 | |
| 799048 | PODESTA GROUP, INC. 52acf3dd-b128-46ba-8d33-c37e8bf15ab4 | Q2 | PODESTA GROUP, INC. | 31680 | EISAI INC. | 2009 | second_quarter | PHA | H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 Pathway for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2009-07-17T15:52:31-04:00 | |
| 799073 | PODESTA GROUP, INC. d90cf385-4edf-41d7-84eb-3f6e614154a0 | Q2 | PODESTA GROUP, INC. | 31680 | MILLENNIUM PHARMACEUTICALS INC | 2009 | second_quarter | PHA | H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine H.R. 1548 Pathway for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act S. 717 21st Century Cancer ALERT (Access to Life Saving Early detection, Research and Treatment) Act | Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2009-07-17T15:54:44-04:00 | |
| 799147 | PODESTA GROUP, INC. 3766470d-f8a6-4751-85ce-4693169e207e | Q2 | PODESTA GROUP, INC. | 31680 | NOVO NORDISK INC | 2009 | second_quarter | PHA | H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine H.R. 1548 Pathway for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act Drug Importation H.R. 1298 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 1232 Pharmaceutical Market Access and Drug Safety Act of 2009 | Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 60000 | 0 | 0 | 2009-07-17T16:01:16-04:00 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE lobbying_activities (
id INTEGER PRIMARY KEY,
filing_uuid TEXT NOT NULL,
filing_type TEXT NOT NULL,
registrant_name TEXT NOT NULL,
registrant_id INTEGER,
client_name TEXT NOT NULL,
filing_year INTEGER NOT NULL,
filing_period TEXT NOT NULL,
issue_code TEXT,
specific_issues TEXT,
government_entities TEXT,
income_amount INTEGER,
expense_amount INTEGER,
is_no_activity INTEGER DEFAULT 0,
is_termination INTEGER DEFAULT 0,
received_date TEXT,
CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
REFERENCES lobbying_filings_raw(filing_uuid)
);
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);